top of page
Immunotherapy Clinical Trials For Mesothelioma
Stereotactic Body Radiation Therapy With Immunotherapy for the Treatment of Mesothelioma
A Study of Immunotherapy Drugs Nivolumab and Ipilimumab in Patients w/Resectable Malignant Peritoneal Mesothelioma
Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
Intratumor Injection of Anti-Mesothelin Immunotoxin LMB-100 With Ipilimumab in Malignant Mesothelioma
DuRvalumab With chEmotherapy as First Line treAtment in Advanced Pleural Mesothelioma
A Beta-only IL-2 ImmunoTherapY (ABILITY) Study
The Registry of Oncology Outcomes Associated With Testing and Treatment
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid Tumors
Study of TBio-6517 Given Alone or in Combination With Pembrolizumab in Solid Tumors
bottom of page